ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
Comparing VAS mortality reduction to other interventions
2
3
VASBednetsAzithromycin
4
Inputs
5
All-cause intent-to-treat mortality reduction24%17%14%
6
Estimated population coverage87%70%90%
7
Mortality reduction per treated28%24%16%
8
Approx. control group mortality rate (per 1,000 child years)25.4937.815.9
9
10
Scenario 1: VAS has mortality effects in kids w/o VAD
11
VAD rate in trials59%
12
Mortality effect above VAD threshold is X% of effect below threshold33%
*Key parameter. A guess.
13
Estimated VAS mortality effect size per treated, among population with vitamin A deficiency38%
14
Estimated VAS mortality effect size per treated, among population without vitamin A deficiency13%
15
16
Scenario 2: VAS has no mortality effects in kids w/o VAD
17
Mortality effect above VAD threshold is X% of effect below threshold0%
18
Estimated VAS mortality effect size per treated, among population with vitamin A deficiency47%
19
Estimated VAS mortality effect size per treated, among population without vitamin A deficiency0%
20
21
Comparison with seasonal malaria chemoprevention (SMC) (no direct all-cause mortality effect)
22
Percent of deaths from malaria in under-5 children, Sub-Saharan Africa, 20050.15
23
Reduction in clinical malaria among children targeted0.75
24
Internal validity adjustment — SMC95%
25
External validity adjustment — SMC100%
26
Estimated coverage in trials considered in GiveWell's meta-analysis90%
27
Expected reduction in malaria cases among children treated79%
28
Ratio of the reduction in malaria mortality to the reduction in malaria incidence100%
29
Indirect deaths averted per malaria death averted0.5
30
Proportion of annual direct malaria mortality occurring in high-transmission season70%
31
Total estimated ACM effect (during the SMC season)17.9%
32
Total estimated ACM effect (annualized)12.5%
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100